GENE ONLINE|News &
STAAR Surgical Reports $94 Million in Preliminary Q1 2026 Sales, Driven by International Demand for Implantable Collamer Lenses
STAAR Surgical has released its preliminary net sales figures for the first quarter of 2026, reporting an estimated $94 million in revenue. The company stated that this represents a 15% increase compared to the same period in 2025, when net sales totaled $81.1 million. These results remain subject to final adjustments and review as part of the company’s standard financial reporting process.
According to STAAR Surgical, growth during the quarter was driven by increased demand for its implantable Collamer lenses (ICLs), particularly in international markets. The company highlighted strong performance in regions such as China, Japan, and Europe, which contributed significantly to overall sales growth. Finalized financial results for the first quarter are expected to be announced later this month.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 8, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Study Identifies Linear RAG-Scanning Mechanism in Secondary Igκ Light Chain Rearrangement
2026-04-16
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
